Hereditary spastic paraplegia: Spastin phenotype and function

Archives of Neurology

Volumn 61, Issue 6, 2004, Pages 830-833

  Fink, John K ^a   Rainier, Shirley ^a  

^a Box 0940 ^*

Author keywords

[No Author keywords available]

Indexed keywords

SPASTIN;

CLINICAL FEATURE; COGNITIVE DEFECT; CORPUS CALLOSUM; DISEASE SEVERITY; EDITORIAL; GAIT DISORDER; GENE; GENE EXPRESSION; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; MUSCLE WEAKNESS; PHENOTYPE; PRIORITY JOURNAL; SPG4 GENE; SYMPTOMATOLOGY;

ADENOSINE TRIPHOSPHATASES; CALCIUM-BINDING PROTEINS; HUMANS; MUTATION; PHENOTYPE; SPASTIC PARAPLEGIA, HEREDITARY;

EID: 2942531080     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.61.6.830     Document Type: Editorial

References (32)

1. Fink JK. Hereditary spastic paraplegia: nine genes and counting. Arch Neurol. 2003;60:1045-1049.
2. Blumen SC, Bevan S, Abu-Mouch S, et al. A locus for complicated hereditary spastic paraplegia maps to chromosome 1q24-q32. Ann Neurol. 2003;54:796-803.
3. Simpson MA, Proukakis C, Cross H, Patton MA, Crosby AH. Maspardin is mutated in Mast syndrome, a form of hereditary spastic paraplegia associated with dementia [abstract]. Am J Hum Genet. 2003;73:179.
4. Hazan J, Fonknechten N, Mavel O, et al. Spastin, a new AAA protein, is altered in the most frequent form of autosomal dominant spastic paraplegia. Nat Genet. 1999;23:296-303.
5. Harding AE. Hereditary spastic paraplegias. Semin Neurol. 1993;13:333-336.
6. Heinzlef O, Paternotte C, Mahieux F, et al. Mapping of a complicated familial spastic paraplegia to locus SPG4 on chromosome 2p. J Med Genet. 1998;35:89-93.
7. Lizcano-Gil LA, Garcia-Cruz D, Bernal-Beltran MDP, Hernandez A. Association of late onset spastic paraparesis and dementia: probably an autosomal dominant form of complicated paraplegia. Am J Med Genet. 1997;68:1-6.
8. Byrne PC, Webb S, McSweeney F, Burke T, Hutchinson M, Parfrey N. Linkage of AD HSP and cognitive impairment to chromosome 2p: haplotype and phenotype analysis indicates variable expression and low or delayed penetrance. Eur J Hum Genet. 1998;6:275-282.
9. Byrne PC, McMonagle P, Webb S, Fitzgerald B, Parfrey NA, Hutchinson M. Age-related cognitive decline in heredtiary spastic paraparesis linked to chromosome 2p. Neurology. 2000;54:1510-1517.
10. Reid E, Grayson C, Rubinsztein DC, Rogers MT, Rubinsztein JS. Subclinical cognitive impairment in autosomal dominant "pure" hereditary spastic paraplegia. J Med Genet. 1999;36:797-798.
11. Tedeschi G, Allocca S, DiCostanzo A, et al. Multisystem involvement of the central nervous system in Strumpell's disease: a neurophysiological and neuropsychological study. J Neurol Sci. 1991;103:55-60.
12. Tallaksen CME, Guichart-Gomez E, Verpillat P, et al. Subtle cognitive impairment but no dementia in patients with spastin mutations [abstract]. Arch Neurol. 2003;60:1113-1118.
13. Webb S, Coleman D, Byrne P, et al. Autosomal dominant hereditary spastic paraparesis with cognitive loss linked to chromosome 2p. Brain. 1998;121:601-609.
14. Wharton SB, McDermott CJ, Grierson AJ, et al. The cellular and molecular pathology of the motor system in hereditary spastic paraparesis due to mutation of the spastin gene. J Neuropathol Exp Neurol. 2003;62:1166-1177.
15. Orlacchio A, Kawarai T, Totaro A, et al. Hereditary spastic paraplegia: clinical genetic study of 15 families. Arch Neurol. 2004;61:849-855.
16. Winner B, Uyanik G, Gross C, et al. Clinical progression and genetic analysis in hereditary spastic paraplegia with thin corpus callosum in spastic gait gene 11 (SPG11). Arch Neurol. 2004;61:117-121.
17. Casali C, Valente EM, Bertini E, et al, Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum. Neurology. 2004;62:262-268.
18. Martinez-Murillo F, Kobayashi H, Pegoraro E, et al. Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15. Neurology. 1999; 53:50-56.
19. Svenson IK, Kloos MT, Gaskell PC, et al. An intragenic modifier of hereditary spastic paraplegia due to spastin gene mutation suggests a role for cyclin-dependent kinase 5 in HSP pathogenesis [abstract]. Am J Hum Genet. 2003;73 (suppl):550. Abstract 2238.
20. Charvin D, Fonknechten N, Cifuentes-Diaz C, et al. Mutations in SPG4 are responsible for a loss of function of spastin, an abundant neuronal protein localized to the nucleus [abstract]. Am J Hum Genet. 2002;71:516.
21. Garbern JY, Yool DA, Moore GJ, et al. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain. 2002;125:551-561.
22. McNally KP, Bazirgan OA, McNally FJ. Two domains of P80 katanin regulate microtubule severing and spindle pole targeting by P60 katanin. J Cell Sci. 2000; 113(pt 9):1623-1633.
23. Ciccarelli FD, Proukakis C, Patel H, et al. The identification of a conserved domain in both spartin and spastin, mutated in hereditary spastic paraplegia. Genomics. 2003;81:437-441.
24. Errico A, Ballabio A, Rugarli EI. Spastin, the protein mutated in autosomal dominant hereditary spastic paraplegia, is involved in microtubule dynamics. Hum Mol Genet. 2002;11:153-163.
25. McDermott CJ, Grierson AJ, Wood JD, et al. Hereditary spastic paraparesis: disrupted intracellular transport associated with spastin mutation. Ann Neurol. 2003; 54:748-759.
26. Azim AC, Hentati A, Haque MFU, Hirano M, Ouachi K, Siddique T. Spastin, a new AAA protein, binds to α and β tubulins [abstract]. Am J Hum Genet. 2000;67 (suppl 2):197. Abstract 1056.
27. Casari G, Fusco M, Ciarmatori S, et al. Spastic paraplegia and OXPHOS impairment caused by mutations in paraplegin, a nuclear-encoded mitochondrial metalloprotease. Cell. 1998;93:973-983.
28. Hansen JJ, Durr A, Cournu-Rebeix I, et al. Hereditary spastic paraplegia SPG13 is associated with a muatation in the gene encoding the mitochondrial chaperonin Hsp60. Am J Hum Genet. 2002;70:1328-1332.
29. Reid E, Kloos M, Ashley-Koch A, et al. A kinesin heavychain (KIF5A) mutation in hereditary spastic paraplegia (SPG10). Am J Hum Genet. 2002;71:1189-1194.
30. Puls I, Jonnakuty C, LaMonte BH, et al. Mutant dynactin in motor neuron disease. Nat Genet. 2003;33:455-456.
31. Hafezparast M, Klocke R, Ruhrberg C, et al. Mutations in dynein link motor neuron degeneration to defects in retrograde transport. Science. 2003;300:808-812.
32. Fassier C, Tarrade A, Charvin D, et al. Generation and characterization of mouse models of spastic paraplegia caused by mutation of SPG4 gene [abstract]. Am J Hum Genet. 2003;73:547.